PDPs need sustained, diverse, and flexible funding to increase their impact on global health and development.

To account for the relatively lengthy timelines of medical technology development and attrition rates, PDPs require stable long-term funding and investment across every stage of the research process—from discovery and epidemiology to clinical trials and access—and sufficient latitude to shift funding across their pipelines to prioritize the most promising and impactful research programs. New innovative financing mechanisms are needed to incentivize increased participation in global health product development by the private sector. To fully unlock the potential of PDPs, increased investments are needed from all parties and sectors, including BRICS and low- and middle-income countries.